Vericiguat in heart failure patients: analyzing safety, tolerability, and quality of life via meta-analysis of randomized controlled trials

Tanriverdi, L. H.Dogan, M. M.Banach, M.2026-04-042026-04-0420240195-668X1522-9645https://doi.org/10.1093/eurheartj/ehae666.1082https://hdl.handle.net/11616/109190European-Society-of-Cardiology Congress (ESC) -- AUG 30-SEP 02, 2024 -- London, ENGLAND[No abstract available]eninfo:eu-repo/semantics/openAccessVericiguat in heart failure patients: analyzing safety, tolerability, and quality of life via meta-analysis of randomized controlled trialsConference Object4510.1093/eurheartj/ehae666.1082WOS:001345267600023Q10000-0003-4263-5234